Package 65219-056-29

{"route": ["INTRAVENOUS"], "spl_id": "935c5395-1f0b-4277-97de-8b1cf1252d1e", "openfda": {"upc": ["0365219056096", "0365219052098", "0365219054092"], "unii": ["4J9FJ0HL51", "CI71S98N1Z"], "rxcui": ["1928567", "1928569", "2667657"], "spl_set_id": ["475f5cd7-45bd-412a-b419-9962585d6cda"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 TRAY (65219-056-29)  / 50 mL in 1 VIAL (65219-056-09)", "package_ndc": "65219-056-29", "marketing_start_date": "20200210"}], "brand_name": "Potassium Phosphates", "product_id": "65219-056_935c5395-1f0b-4277-97de-8b1cf1252d1e", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Potassium Compounds [CS]", "Potassium Compounds [CS]", "Potassium Salt [EPC]", "Potassium Salt [EPC]"], "product_ndc": "65219-056", "generic_name": "Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Potassium Phosphates", "active_ingredients": [{"name": "DIBASIC POTASSIUM PHOSPHATE", "strength": "236 mg/mL"}, {"name": "MONOBASIC POTASSIUM PHOSPHATE", "strength": "224 mg/mL"}], "application_number": "NDA212832", "marketing_category": "NDA", "marketing_start_date": "20200210", "listing_expiration_date": "20261231"}